Gastric and Pancreatic Lesions in Rats Treated with a Pan-CDK Inhibitor

Toxicologic Pathology

Volumn 33, Issue 7, 2005, Pages 784-791

  Ramiro Ibáñez, Fernando ^a   Trajkovic, Dusko ^a   Jessen, Bart ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

apoptosis; cancer; Cyclin dependent kinases; islets of Langerhans; pancreas; stomach; topoisomerase

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME INHIBITOR; PEPTIDE FRAGMENT; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR (445 733); VON WILLEBRAND FACTOR (445-733);

ANIMAL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MALE; NECROSIS; PANCREAS; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; STOMACH;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; NECROSIS; PANCREAS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; STOMACH; VON WILLEBRAND FACTOR;

EID: 33644801394     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230500455862     Document Type: Article

References (35)

1. Aguda BD, Algar CK A structural analysis of the qualitative networks regulating cell cycle and apoptosis Cell Cycle 2003 2 538-44
2. Arguello F, Alexander M, Sterry JA, Tudor G, Smith EM, Kalavar NT, Greene JF, Koss W, Morgan CD, Stinson SF, Siford TJ, Alvord WG, Klabansky RL, Sausville EA Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts Blood 1998 91 2482-90
3. Bock T The source(s) for new pancreatic beta cells in adult life Bioessays 2004 26 1156-9
4. Bouwens L Transdifferentiation versus stem cell hypothesis for the regeneration of islet beta cells in the pancreas Microsc Res Tech 1998 43 332-6
5. Buolamwini JK Cell cycle molecular targets in novel anticancer drug discovery Curr Pharm Des 2000 6 379-92
6. Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M, West SC CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair Nature 2005 434 598 604
7. 3 focal contacts EMBO J 1999 18 2106 2118
8. Fischer PM, Gianella-Borradori A CDK inhibitors in clinical development for the treatment of cancer Expert Opin Investig Drugs 2003 12 955-70
9. Foye WO Cancer Chemotherapeutic Agents 1995 Washington, DC American Chemical Society
10. Hoshi T, Sasano H, Yabuki N, Ohara S, Konno R, Asaki S, Toyota T, Tateno H, Nagura H Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis Anticancer Res 1998 18 4347-53
11. Hunter T, Pines J Cyclins and cancer II: Cyclin D and CDK inhibitors come of age Cell 1994 79 573-82
12. Johnson DG, Walker CL Cyclins and cell cycle checkpoints Annu Rev of Pharmacol and Toxicol 1999 295 312
13. Kim YS Apoptosis of PC12 cells in serum deprived media induces apoptosis of neuronal cells through activating microglia FASEB J 2001 15 A511
14. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharva S, Bronson RT, Akashi K, Sicinski P Mouse development and cell proliferation in the absence of D-cyclins Cell 2004 118 477-91
15. Lilja L, Yan SN, Webb DL, Juntti-Berggren L, Berggren PO, Bark C Cyclin-dependent kinase 5 promotes insulin exocytosis J Biol Chem 2001 276 34199 205
16. Lo SS, Lo SH, Lo SH Cleavage of cten by caspase-3 during apoptosis Oncogene 2005 24 4311-4
17. 3H-timidine autoradiographic investigation Pancreas 2002 24 153-60
18. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S, Dubus P, Barbacid M Mammalian cell cycle without the D-type cyclin dependent kinases CDK4 and CDK6 Cell 2004 118 493 504
19. Massague J G1 cell cycle control and cancer Nature 2004 432 298 306
20. Modlin IM, Kidd M, Lye KD, Wright NA Gastric stem cells: an update Keio J Med 2003 52 134-7
21. Pardee AB G1 events and regulation of cell proliferation Science 1989 246 603-8
22. Ribas J, Roix J Cell differentiation, caspase inhibition, and macro-molecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cell from apoptosis triggered by two CDK inhibitor drugs Exp Cell Res 2004 295 9 24
23. Sausville EA Winning/losing protein kinase antagonists: what have we learned? PharmaDiscovery 2005 2005 Washington, DC Kinases in Drug Discovery 10-12 May 2005
24. Sausville EA, Lush RD, Headlee D, Smith AC, Figg WD, Arbuck SG, Senderowicz AM, Fuse E, Tanii H, Kuwabara T, Kobayashi S Clinical pharmacology of UCN-01: initial observations and comparison to preclinical models Cancer Chemother Pharmacol 1998 42 Suppl S54 9
25. Sawyers C Targeted cancer therapy Nature 2004 432 294-7
26. Schafer KA The cell cycle: a review Vet Pathol 1998 35 461-78
27. Sedlacek HH, Czech J, Naik R, Kaur G, Worland P, Losiewicz M, Parker B, Carlson B, Smith A, Senderowicz A, Sausville E Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy Int J Oncol 1996 9 1143-68
28. Senderowicz AM Small-molecule cyclin-dependent kinase modulators Oncogene 2003 22 6609-20
29. Senderowicz AM, Sausville EA Preclinical and clinical development of cyclin-dependent kinase modulators J Nat Cancer Inst 2000 92 376-87
30. cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo Cell 1995 83 1159-69
31. Slee EA, Adrain C, Martin SJ Executioner caspases -3, -6 and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis J Biol Chem 2001 276 7320-6
32. Stadler WM, Vogelzang NJ, Amato R, Sosman J, Taber D, Liebowitz D, Vokes EE Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II consortium study J Clin Oncol 2000 18 371-5
33. Weaver C, Bishop AE, Polar JM Pancreatic changes elicited by chronic administration of excess L-arginine Exp Mol Pathol 1994 60 71 87
34. Woesner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH Proliferation and cell cycle dependent differences in the expression of the 170 kDa and 180 kDa forms of topoisomerase II in NIH-3T3 cells Cell Growth Diff 1991 2 209-14
35. Zhai S, Senderowicz AM, Sausville EA, Figg WD Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development Ann Pharmacother 2002 36 905-11